MANAGEMENT TEAM

Dr. Himabindu Gaddipati is a practicing Oncologist in San Diego, CA. After graduating from Andhra Medical College, Visakhapatnam in 1999 she pursued 8 years of post-graduate training at University of Virginia in the United States. She completed Internal Medicine residency followed by post-doc fellowships in Genetics and Molecular Biology from the University of Pennsylvania, PA and Hematology/Oncology from University Hospitals/Case Western Reserve University. She served as a visiting scientist at the Wistar Research Institute. She was subsequently trained as an Interagency Taskforce Oncology Product Development post-doc fellow at the National Cancer Institute, Bethesda and The Food and Drug Administration (FDA).

She gained valuable insight about the regulatory requirements for marketing approval of drugs in the division of oncology at the FDA. At the National Cancer Institute, she served as an analyst for the Federal Small Business Innovation Research (SBIR Program) and also completed a certificate program in Technology Transfer. She also obtained a solid overview about the process of technology commercialization at the Wharton School of Business where she completed her Master’s Degree. She is currently the co-chairperson  for the Biocom oncology group, a network of more than 120 organizations including hospitals, research institutions, companies and foundations engaged in cancer related activities in the Southern California.

Dr. Himabindu Gaddipati, MD, EMTM

Chairman and Managing Director

Dr. Himabindu Gaddipati
Dr. Himabindu Gaddipati

MD, EMTM

Chairman and Managing Director

Dr. Mandar Kulkarni
Dr. Mandar Kulkarni, PhD

Chief Executive Officer

Dr. Mandar Kulkarni
Dr. Mandar Kulkarni
PhD

Chief Executive Officer

After earning his doctorate in molecular carcinogenesis from Purdue University, Dr. Kulkarni was selected to become a T32 fellow at the Yale School of Medicine and was awarded a young scientist award for his work in the structural biology and signal transduction. As a senior scientist at M/Z Diagnostics, he managed business, obtained an NIH-SBIR grant as a PI, and was awarded a Young scientist award by the FSG. At Sandor Lifesciences, as the Head of Molecular Biology and Genomics, he designed and executed numerous NGS, microarray and bioinformatics projects.

Then, as the Chief Technology Officer at CGIndia, he managed all operations and lead the development of research services, diagnostics, biopharma services, R&D, and genomics-based clinical assays in the area of precision oncology. He was also responsible for ensuring the financial success of the Indian business unit and established several high value collaborations in the Indian personalized oncology space. Currently, he is also a key member of the senior executive team and drives the scientific agenda at Lumiseek.

Mr. Natarajan holds dual Masters’ Degrees in Chemistry & Pharmacokinetics from Birla Institute of Technology & Sciences, Pilani and Medical College of Virginia, VA, USA. Mr. Sreevatsa Natarajan is a scientist-entrepreneur with more than 15 years of global R&D and business experience in the life sciences industry. He has held leadership positions across various domains in companies such as Purdue Pharma, Vertex Pharma, Glenmark Pharma and Aurigene. He has played key roles in developing & launching several novel drugs across various therapeutic areas such as inflammation, infectious diseases, neurology etc.

Mr. Natarajan brings extensive experience on the science side in applying pharmacology & pharmacokinetics to drug development problems and on the business side in structuring deals and facilitating collaborative alliances in a global context.

Mr. Sreevatsa Natarajan
Mr. Sreevatsa Natarajan, MS

Chief Business Adviser

Mr. Sreevatsa Natarajan
Mr. Sreevatsa Natarajan

MS

Chief Business Adviser

Loganathan Doraisamy
Dr. Loganathan Doraisamy, MSc, PhD

Chief Technology Officer

Loganathan Doraisamy
Dr. Loganathan Doraisamy
MSc, PhD

Chief Technology Officer

Dr. Doraisamy has expertise in the areas of nano-bio technologies, biomarker detection, microfluidics and next generation sequencing technologies for healthcare and bio-defense. He has successfully led collaborations between various stakeholders such as biotech industry, university researchers, clinical and government laboratories, US government funding agencies, private investors and customers, enabling R&D, product development and commercialization.

 

Dr. Keswarpu possesses over 20 years of professional health science experience as a Physician Scientist and also held numerous leadership positions and has driven product innovations in healthcare while utilizing her clinical knowledge of pathology and oncology. She earned a postgraduate degree as an M.D. in Pathology from St. John’s Medical College in India and a DNB in Pathology from the National Board of Exams in India. She also holds Bachelor of Medicine and Bachelor of Surgery degrees from MKCG Medical College in India. Additionally, she completed the Executive Program at the Indian School of Business. Dr. Keswarpu has been granted multiple patents and has published scientific articles in many journals. She is also the recipient of major awards and honors for her work in academic settings and during her engagements in corporate roles.

Dr. Payal Keswarpu, MD
Dr. Payal Keswarpu, MD

Lab Director – Pathology

Dr. Payal Keswarpu, MD
Dr. Payal Keswarpu

MD

Lab Director – Pathology

Archit Sahai, MBA

VP – Growth & Strategy

 Archit Sahai
MBA

VP – Growth & Strategy

Archit Sahai leads growth and strategic initiatives at Biolara-VCR Park. Over the past decade, he’s worked across multiple sides of the healthcare ecosystem and specializes in launching and scaling cutting-edge life sciences innovations— translating science into commercial strategy at Roche and Novartis, building and launching digital health products at Innovaccer, and pioneering precision medicine adoption at Strand. At Biolara, he works across a preventive healthcare initiative, oncology startup investing, and digital health platform development. Archit holds an MBA from Indian School of Business and a Masters in Biotechnology.

Dr. Shruti Krishnan’s academic background includes a Bachelor of Science in Microbiology and a Master’s in Applied Microbiology from the University of Madras, India, followed by a Master’s in Forensic Science from The University of Western Australia. She earned her PhD from The University of Western Australia, Perth, researching combined immunotherapy to eradicate tumours and induce memory against murine mesothelioma, gaining insights into tumour microenvironment immunosuppression. Her experience encompasses immunology, microbiology, and forensic molecular biology, with a strong track record in overseeing research and development projects and fostering collaborations with external organizations. This often includes managing budgets, grant writing, mentoring, and applying expertise in relevant scientific fields.

Dr Shruti Krishnan, PhD

R&D and Alliance Manager

Dr Shruti Krishnan
PhD

R&D and Alliance Manager

Disha Chander, MPH

Clinical Research Manager

Disha Chander
MPH

Clinical Research Manager

Disha comes with a multidisciplinary background in biotechnology, public health, and global health research. She holds a B.Tech in Biotechnology from VIT Vellore and a Masters in Public Health( MPH) from New York University, USA. Prior to returning to India, she worked in the United States across clinical research and population health programs. At the New York Blood Center, she supported FDA-sponsored clinical trials through the National Marrow Donor Program in collaboration with Be The Match- the world’s largest registry for bone marrow and stem cell transplantation. She also worked on the government-funded Medicaid program, designing care plans and targeted interventions for patients with multiple comorbidities, addressing social determinants of health to reduce hospitalizations and improve quality of life. During the COVID-19 pandemic, Disha actively contributed to public health response initiatives, including The Access Challenge with Africa CDC, African Union, and WHO, supporting intervention design to improve maternal health outcomes across African populations. She collaborated with Harvard medical students to mobilize essential resources for disproportionately impacted Latinx and immigrant communities in New York City and supported national COVID-19 data aggregation efforts for research and academia.

Her work focuses on evidence-based research, systems strengthening, and translating science into meaningful health outcomes. As a Clinical Research Manager, she oversees the planning, coordination, and execution of clinical research activities, ensuring regulatory compliance, data integrity, and cross-functional collaboration.

Satish Chokka holds a Bachelor’s degree in Electrical and Electronics Engineering from JNTU Kakinada, along with Master’s degrees in Global Logistics & Supply Chain Management and Business Analytics & Business Intelligence. He brings nearly a decade of professional experience across supply chain management, procurement, operations, and contract management, with strong exposure to shipbuilding and ship construction environments. He has worked as a Senior Analyst – Procurement and as a Supply Chain Analyst, supporting large-scale industrial and infrastructure projects. His expertise includes business analysis, vendor management, procurement and contract management, managing customs clearance for exports and imports, handling EXIM operations, and conducting business analysis across ports, logistics, manufacturing, and service sectors. Satish has led and contributed to supply chain process improvements focused on efficiency, cost optimization, and operational excellence. He possesses hands-on experience in data visualization and AI-driven analysis, enabling data-backed decision-making. A certified Lean Six Sigma professional, he combines technical expertise, analytical thinking, and continuous improvement methodologies to deliver structured, value-driven business solutions.

Satish Chokka
Satish Chokka, MBA, PGDM-BABI

Manager – Facility Operations & Infra Development projects

Satish Chokka
Satish Chokka
MBA, PGDM-BABI

Manager – Facility Operations & Infra Development projects

Tabitha Pothula
Ms. Tabitha Pothula Pharma MBA

Senior Project Manager

Ms. Lekhasree C B.tech (Biotech)

Junior Scientist

cancer research, discover, cure, clinical